Clinical Trial Update: Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair [Phase 2, Phase 3]

View source ↗

Summary

The trial investigates tirofiban to reduce thromboembolic events during endovascular repair of unruptured intracranial aneurysms, across Phase 2 and Phase 3, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Unruptured Intracranial Aneurysm

Drugs mentioned

• Aggrastat (tirofiban)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Unruptured Intracranial Aneurysm, Flow Diverter | Phase 2, Phase 3 | Status: COMPLETED